Commit To Purchase InVivo Therapeutics Holdings Corp At $7.50, Earn 34.8% Annualized Using Options
October 09, 2015 at 11:48 AM EDT
Investors eyeing a purchase of InVivo Therapeutics Holdings Corp (NVIV) shares, but tentative about paying the going market price of $8.63/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $7.50 strike, which has a bid at the time of this writing of 5 cents..